K. Stephen Suh

1.9k total citations
33 papers, 1.2k citations indexed

About

K. Stephen Suh is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, K. Stephen Suh has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Pathology and Forensic Medicine and 8 papers in Oncology. Recurrent topics in K. Stephen Suh's work include Lymphoma Diagnosis and Treatment (8 papers), Fibroblast Growth Factor Research (3 papers) and MicroRNA in disease regulation (3 papers). K. Stephen Suh is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Fibroblast Growth Factor Research (3 papers) and MicroRNA in disease regulation (3 papers). K. Stephen Suh collaborates with scholars based in United States, Jordan and Canada. K. Stephen Suh's co-authors include André Goy, Andrew L. Pecora, Nehad M. Ayoub, Pritish K. Bhattacharyya, Ciaran Mannion, Christian Castañeda, Betty Tai, Mohamed R. Akl, Poonam Nagpal and Sathyen A. Prabhu and has published in prestigious journals such as Blood, Journal of Hepatology and Molecular Therapy.

In The Last Decade

K. Stephen Suh

32 papers receiving 1.1k citations

Peers

Countries citing papers authored by K. Stephen Suh

Since Specialization

Citations

This map shows the geographic impact of K. Stephen Suh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Stephen Suh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Stephen Suh more than expected).

Fields of papers citing papers by K. Stephen Suh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Stephen Suh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Stephen Suh. The network helps show where K. Stephen Suh may publish in the future.

Co-authorship network of co-authors of K. Stephen Suh

This figure shows the co-authorship network connecting the top 25 collaborators of K. Stephen Suh. A scholar is included among the top collaborators of K. Stephen Suh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Stephen Suh. K. Stephen Suh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prolactin Induced Protein (PIP) is a potential biomarker for early stage and malignant breast cancer 2018 ·The Breast ·(unknown), Themba Nyirenda, Kishan Patel, (unknown), (unknown), Takemi Tanaka, (unknown), (unknown), (unknown), (unknown), Ciaran Mannion, Grace Y. Lee, André Goy, Andrew L. Pecora, K. Stephen Suh	14
2	The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer 2016 ·Journal of Ovarian Research ·(unknown), (unknown), Sakshi Balwani, Takemi Tanaka, (unknown), Ahmed M. Hassan, (unknown), (unknown), (unknown), (unknown), (unknown), André Goy, Andrew L. Pecora, K. Stephen Suh	30
3	Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents 2016 ·Oncotarget ·Arati A. Inamdar, André Goy, Nehad M. Ayoub, (unknown), Lucia Oton, (unknown), (unknown), Yuting Lin, Andrew L. Pecora, K. Stephen Suh	39
4	Pediatric Hodgkin lymphoma- biomarkers, drugs, and clinical trials for translational science and medicine 2016 ·Oncotarget ·Poonam Nagpal, Mohamed R. Akl, Nehad M. Ayoub, (unknown), (unknown), Betty Tai, (unknown), (unknown), Pritish K. Bhattacharyya, Michael B. Harris, André Goy, Andrew L. Pecora, K. Stephen Suh	32
5	Prediction of clinical outcomes using the pyrolysis, gas chromatography, and differential mobility spectrometry (Py-GC-DMS) system 2016 ·Journal of Analytical and Applied Pyrolysis ·Arati A. Inamdar, (unknown), Yvonne Remache, (unknown), (unknown), (unknown), (unknown), Andrew L. Pecora, André Goy, K. Stephen Suh	1
6	Clinical decision support systems for improving diagnostic accuracy and achieving precision medicine 2015 ·PubMed ·Christian Castañeda, (unknown), Ciaran Mannion, Pritish K. Bhattacharyya, (unknown), Andrew L. Pecora, André Goy, K. Stephen Suh	224
7	Ensuring Biobank Value Through Effective Utilization 2015 ·Biopreservation and Biobanking ·Sherilyn J. Sawyer, (unknown), K. Stephen Suh	5
8	A combination of high dose rate (10X FFF/2400 MU/min/10 MV X-rays) and total low dose (0.5 Gy) induces a higher rate of apoptosis in melanoma cells in vitro and superior preservation of normal melanocytes 2015 ·Melanoma Research ·(unknown), Andrew L. Pecora, (unknown), (unknown), (unknown), (unknown), (unknown), Jennifer Jiang, (unknown), (unknown), (unknown), Diana I. Sánchez, Neha Agarwal, Stephanie Jeong, (unknown), Yvonne Remache, André Goy, (unknown), (unknown), K. Stephen Suh	13
9	Blocking the Adhesion Cascade at the Premetastatic Niche for Prevention of Breast Cancer Metastasis 2015 ·Molecular Therapy ·Shin Ae Kang, Nafis Hasan, Aman P. Mann, Wei Zheng, Lichao Zhao, Lynsie Morris, Weizhu Zhu, Yan D. Zhao, K. Stephen Suh, William C. Dooley, David E. Volk, David G. Gorenstein, Massimo Cristofanilli, Hallgeir Rui, Takemi Tanaka	46
10	Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes 2014 ·Journal of Ovarian Research ·(unknown), (unknown), (unknown), Craig Schindewolf, Takemi Tanaka, Rajendra Gharbaran, Hiren Patel, Anil K. Sood, Wei Hu, Ruzeen Patwa, (unknown), (unknown), (unknown), Heejin Lim, André Goy, Andrew L. Pecora, K. Stephen Suh	33
11	Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients 2013 ·Journal of Hematology & Oncology ·Rajendra Gharbaran, André Goy, Takemi Tanaka, (unknown), Chris Kim, Nafis Hasan, (unknown), (unknown), Madalina Tuluc, (unknown), Pritish K. Bhattacharyya, Andrew L. Pecora, K. Stephen Suh	25
12	Potential biomarkers for predicting outcomes in CABG cardiothoracic surgeries 2013 ·Journal of Cardiothoracic Surgery ·Isabel R. Preeshagul, Rajendra Gharbaran, (unknown), (unknown), Leonard Y. Lee, (unknown), K. Stephen Suh	26
13	Circulating tumor cells in Hodgkin's lymphoma—A review of the spread of HL tumor cells or their putative precursors by lymphatic and hematogenous means, and their prognostic significance 2013 ·Critical Reviews in Oncology/Hematology ·Rajendra Gharbaran, (unknown), Chris Kim, André Goy, K. Stephen Suh	6
14	Baseline Serum Cytokines Profiles in Mantle Cell Lymphoma Correlates with Outcome 2012 ·Blood ·Anthony R. Mato, James A Greenberg, Mary Putt, K. Stephen Suh, Yvonne Remache, (unknown), (unknown), (unknown), (unknown), Tatyana Feldman, Pritish K. Bhattacharyya, Xiao Yan Yang, Kar Fai Chow, (unknown), Andrew L. Pecora, André Goy	1
15	SOX11 Directly Represses Wnt/β-Catenin Signaling and Identifies a Subgroup of Mantle Cell Lymphoma Patients with Improved Survival with Intensive Treatment 2012 ·Blood ·(unknown), Violetta V. Leshchenko, Melissa Fazzari, Tobias A. Gellen, Javeed Iqbal, (unknown), Lina Nygren, K. Stephen Suh, André Goy, David T. Yang, (unknown), Brad S. Kahl, Amit Verma, Randy D. Gascoyne, Eva Kimby, Birgitta Sander, B. Hilda Ye, Ari Melnick, Samir Parekh	2
16	Cancer Tissue Engineering: A Novel 3D Polystyrene Scaffold for In Vitro Isolation and Amplification of Lymphoma Cancer Cells from Heterogeneous Cell Mixtures 2011 ·Journal of Tissue Engineering ·(unknown), Qing Liu, Yvonne Remache, André Goy, K. Stephen Suh	37
17	Toward an Integrated Knowledge Environment to Support Modern Oncology 2011 ·The Cancer Journal ·(unknown), David A. Decker, Timothy M. Glennon, (unknown), Sascha Losko, Nicholas E. Navin, K. Stephen Suh	5
18	Ovarian cancer biomarkers for molecular biosensors and translational medicine 2010 ·Expert Review of Molecular Diagnostics ·K. Stephen Suh, (unknown), (unknown), Hiren Patel, (unknown), Michael N. Liang, André Goy	75
19	Informatics-guided procurement of patient samples for biomarker discovery projects in cancer research 2008 ·Cell and Tissue Banking ·K. Stephen Suh, Yvonne Remache, (unknown), (unknown), (unknown), (unknown), (unknown), Jian Wang, André Goy	10
20	Doxorubicin, cisplatin, and Corynebacterium parvum in non-small cell bronchogenic carcinoma. 1980 ·PubMed ·Ronny Drapkin, Sigurður Björnsson, (unknown), Donald J. Higby, (unknown), (unknown), (unknown), K. Stephen Suh, (unknown), E. S. Henderson	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact